S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
3 Grocery Store Stocks to Put in Your Cart
Greyscale Bitcoin Trust (OTCMKTS: GBTC) Stock is the Bitcoin Derivative of Choice
Opendoor Technologies (NASDAQ: OPEN) Stock is a Disruptive Housing Play
The Latest: Some Polish hospitals suspend vaccination
Carmaker Stellantis shares jump in Milan, Paris on first day
Alberta leader urges Biden to hear case for Keystone XL
World shares retreat despite strong growth data from China
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
3 Grocery Store Stocks to Put in Your Cart
Greyscale Bitcoin Trust (OTCMKTS: GBTC) Stock is the Bitcoin Derivative of Choice
Opendoor Technologies (NASDAQ: OPEN) Stock is a Disruptive Housing Play
The Latest: Some Polish hospitals suspend vaccination
Carmaker Stellantis shares jump in Milan, Paris on first day
Alberta leader urges Biden to hear case for Keystone XL
World shares retreat despite strong growth data from China
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
3 Grocery Store Stocks to Put in Your Cart
Greyscale Bitcoin Trust (OTCMKTS: GBTC) Stock is the Bitcoin Derivative of Choice
Opendoor Technologies (NASDAQ: OPEN) Stock is a Disruptive Housing Play
The Latest: Some Polish hospitals suspend vaccination
Carmaker Stellantis shares jump in Milan, Paris on first day
Alberta leader urges Biden to hear case for Keystone XL
World shares retreat despite strong growth data from China
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
3 Grocery Store Stocks to Put in Your Cart
Greyscale Bitcoin Trust (OTCMKTS: GBTC) Stock is the Bitcoin Derivative of Choice
Opendoor Technologies (NASDAQ: OPEN) Stock is a Disruptive Housing Play
The Latest: Some Polish hospitals suspend vaccination
Carmaker Stellantis shares jump in Milan, Paris on first day
Alberta leader urges Biden to hear case for Keystone XL
World shares retreat despite strong growth data from China
Log in
ASX:AFP

AFT Pharmaceuticals Limited (AFP.AX) Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
AFT Pharmaceuticals Limited develops, licenses, and sells pharmaceutical products in New Zealand, Australia, Southeast Asia, and internationally. The company offers approximately 130 prescription and non-prescription products for use in the areas of allergy, eye care, first aid, fungal, pain management, and skin care, as well as supplements. It is also involved in the distribution of pharmaceuticals. The company was founded in 1997 and is headquartered in Auckland, New Zealand.

MarketRank™

Overall MarketRank™

0.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Stock Exchange ASX
Industry Drug Manufacturers—Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolASX:AFP
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.aftpharm.com
Phone64 9 488 0232
EmployeesN/A

Debt

Debt-to-Equity Ratio147.87
Current Ratio2.26
Quick Ratio0.87

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive AFP News and Ratings via Email

Sign-up to receive the latest news and ratings for AFP and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











AFT Pharmaceuticals Limited (AFP.AX) (ASX:AFP) Frequently Asked Questions

What stocks does MarketBeat like better than AFT Pharmaceuticals Limited (AFP.AX)?

Wall Street analysts have given AFT Pharmaceuticals Limited (AFP.AX) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but AFT Pharmaceuticals Limited (AFP.AX) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of AFT Pharmaceuticals Limited (AFP.AX)'s key competitors?

Some companies that are related to AFT Pharmaceuticals Limited (AFP.AX) include (CSI) (CSI), (IMCC) (IMCC), 1933 Industries (TGIFF), 28896 (BAMM), AB Science (ABSCF), Abattis Bioceuticals (ATT), Acreage (ACRDF), Agraflora Organics International (AGRA), AgraFlora Organics International (AGFAF), Aleafia Health (ALEAF), American Green (ERBB), Australian Primary Hemp Limited (APH.AX) (APH), Ayr Strategies (AYRWF), Benitec Biopharma (BLT) and Bespoke Extracts (BSPK).
View all of AFP's competitors.

Who are AFT Pharmaceuticals Limited (AFP.AX)'s key executives?

AFT Pharmaceuticals Limited (AFP.AX)'s management team includes the following people:
  • Dr. Hartley Atkinson, Founder, CEO, MD & Exec. Director
  • Ms. Marree Atkinson, Chief of Staff & Exec. Director
  • Mr. Malcolm Tubby B.A., BA(Hon's), ICAEW, ICANZ, CFO & Company Sec.
  • Mr. Murray Keith, Group Marketing Mang.
  • Ms. Ioana Stanescu, Head of Drug Devel.
  • Mr. Calvin Mackenzie, Gen. Mang. of AFT Australia
  • Mr. Scott Crawford, Gen. Mang. of Promoted Products Australasia & South East Asia
  • Ms. Louise Clayton, Director of International Bus.

What is AFT Pharmaceuticals Limited (AFP.AX)'s stock symbol?

AFT Pharmaceuticals Limited (AFP.AX) trades on the ASX under the ticker symbol "AFP."

How big of a company is AFT Pharmaceuticals Limited (AFP.AX)?

AFT Pharmaceuticals Limited (AFP.AX) has a market capitalization of $0.00. AFT Pharmaceuticals Limited (AFP.AX) employs 86 workers across the globe.

What is AFT Pharmaceuticals Limited (AFP.AX)'s official website?

The official website for AFT Pharmaceuticals Limited (AFP.AX) is www.aftpharm.com.

How can I contact AFT Pharmaceuticals Limited (AFP.AX)?

The company can be reached via phone at 64 9 488 0232.

This page was last updated on 1/18/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.